关注
Shitij Kapur
Shitij Kapur
在 kcl.ac.uk 的电子邮件经过验证
标题
引用次数
年份
Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study
TR Marques, S Natesan, EA Rabiner, GE Searle, R Gunn, OD Howes, ...
Psychopharmacology 239 (11), 3439-3445, 2022
112022
Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia
AF Pardiñas, SE Smart, IR Willcocks, PA Holmans, CA Dennison, ...
JAMA psychiatry 79 (3), 260-269, 2022
572022
The Maudsley prescribing guidelines in psychiatry
DM Taylor, TRE Barnes, AH Young
John Wiley & Sons, 2021
17072021
Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance …
A Egerton, A Murphy, J Donocik, A Anton, GJ Barker, T Collier, B Deakin, ...
Schizophrenia bulletin 47 (2), 505-516, 2021
732021
Adenosine A
TR Marques, S Natesan, EA Rabiner, GE Searle, R Gunn, OD Howes, ...
2021
Aberrant salience attribution and psychosis
TT Winton-Brown, S Kapur, C Tamminga, J van Os, U Reininghaus, ...
Psychotic Disorders: Comprehensive Conceptualization and Treatments, 442-450, 2020
12020
Antipsychotics circa 2020: What are we thinking?
G Remington, S Kapur
Neuropharmacology 175, 108181, 2020
22020
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, FE Turkheimer, ...
Molecular psychiatry 24 (10), 1502-1512, 2019
1412019
Small sample sizes and a false economy for psychiatric clinical trials
S Kapur, M Munafò
JAMA psychiatry 76 (7), 676-677, 2019
112019
Regulation of dopaminergic function: An [F-18]-DOPA PET apomorphine challenge study in humans (vol 7, e1027, 2017)
S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, ...
TRANSLATIONAL PSYCHIATRY 9, 2019
2019
Correction: Regulation of dopaminergic function: An [18F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, ...
Translational psychiatry 9 (1), 168, 2019
2019
Bipolar disorder
S Mayor
BMJ: British Medical Journal 364, 2019
42019
The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: a positron emission tomography study
S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, S Natesan, ...
Biological psychiatry 85 (1), 79-87, 2019
682019
Determinants of antidepressant response: implications for practice and future clinical trials
J Rabinowitz, N Werbeloff, FS Mandel, L Marangell, F Menard, S Kapur
Journal of affective disorders 239, 79-84, 2018
72018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ...
The Lancet Psychiatry 5 (10), 797-807, 2018
1812018
Moment-to-moment associations between negative affect, aberrant salience, and paranoia
SHW So, AKC Chau, ER Peters, J Swendsen, PA Garety, S Kapur
Cognitive Neuropsychiatry 23 (5), 299-306, 2018
412018
Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis (vol 7, e1245, 2017)
T Winton-Brown, A Schmidt, JP Roiser, OD Howes, A Egerton, ...
TRANSLATIONAL PSYCHIATRY 8, 2018
2018
Effects of risperidone and aripiprazole on serum levels of prolactin, testosterone and estradiol in female patients with schizophrenia
XJ Jiang, FX Wu, JP Zhang, L Shi, JQ Hu, HZ Zhu, B Xiao, WC Lin, ...
Drug Research 68 (07), 410-414, 2018
222018
ANUSCRIPT
S Jauhar, M Veronese, MM Nour, M Rogdaki, P Hathway, S Natesan, ...
2018
Correction: Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, ...
Translational psychiatry 8, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–20